Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,709 public trials 1,045 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Completed

2nd Line Erlotinib Treatment With (Out) Chemotherapy of Advanced Non Small Cell Lung Cancer (NSCLC)

NCT00835471

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Jeroen Bosch Ziekenhuis 's-Hertogenbosch, Netherlands
  • VU medisch centrum Amsterdam, Netherlands
  • Rode Kruis Ziekenhuis Beverwijk, Netherlands
  • Amphia Ziekenhuis Breda, Netherlands
View all 14 locations
View Trial Details
Completed

Paclitaxel-Carboplatin-Bevacizumab +/- Nitroglycerin in Metastatic Non-Squamous-Non-Small Cell Lung Cancer

NCT01171170

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Jeroen Bosch Ziekenhuis 's-Hertogenbosch, Netherlands
  • VU medisch centrum Amsterdam, Netherlands
  • Amphia Ziekenhuis Breda, Netherlands
  • Catharina-Ziekenhuis Eindhoven, Netherlands
View Trial Details
Completed

Pemetrexed Disodium With or Without Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV or Recurrent Non-Small Cell Lung Cancer

NCT00950365

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, +19 more
Locations
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • University of Massachusetts Memorial Health Care Worcester, Massachusetts, United States
  • Albert Einstein College of Medicine The Bronx, New York, United States
  • Bronx River Medical Associates PC The Bronx, New York, United States
View Trial Details
Completed

A Study of Personalized Neoantigen Cancer Vaccines

NCT03794128

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +25 more
Locations
  • University of Chicago Medicine Comprehensive Cancer Center Chicago, Illinois, United States
  • Columbia University Medical Center, Herbert Irving Comprehensive Cancer Center New York, United States
  • The Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
  • Tennessee Oncology Nashville, Tennessee, United States
View Trial Details
Completed

A Study of Abemaciclib (LY2835219) in Combination With Another Anti-cancer Drug in Participants With Lung Cancer (NSCLC)

NCT02079636

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • UCLA Department of Medicine-Hematology/Oncology Los Angeles, California, United States
  • University of California, Davis - Health Systems Sacramento, California, United States
  • Indiana Cancer Pavilion Indianapolis, Indiana, United States
View Trial Details
Completed

A Study of Carboplatin and Pemetrexed Plus Demcizumab (OMP-21M18) in Subjects With Non-Squamous Non-Small Cell Lung Cancer

NCT01189968

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations
  • Royal Brisbane & Women's Hospital Herston, Queensland, Australia
  • Ashford Cancer Centre Research Kurralta Park, South Australia, Australia
  • Monash Medical Centre Clayton, Victoria, Australia
  • Sir Charles Gairdner Hospital Nedlands, Western Australia, Australia
View Trial Details

Related conditions